Viewing Study NCT02325635


Ignite Creation Date: 2025-12-24 @ 10:13 PM
Ignite Modification Date: 2026-01-02 @ 1:07 PM
Study NCT ID: NCT02325635
Status: COMPLETED
Last Update Posted: 2015-11-13
First Post: 2014-12-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Prospective Trial of an Endoscopic Quality Improvement Project
Sponsor: Mayo Clinic
Organization:

Study Overview

Official Title: A Prospective Randomized Controlled Trial of an Endoscopic Quality Improvement Project-2 (EQUIP-2) to Improve Adenoma Detection in Screening and Surveillance Colonoscopy
Status: COMPLETED
Status Verified Date: 2015-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: Equip 2
Brief Summary: Randomized prospective multi-site validation study.
Detailed Description: GI practice sites that have recently agreed to participate in the GIQuIC program will be randomized on a site-basis, to the EQUIP intervention or control.

Baseline ADR and polyp/surveillance predication accuracy will be collected for approximately 3 months.

Sites randomized to the EQUIP intervention will undergo face-to-face training by a study investigator, followed by active monitoring and feedback.

Control sites will not receive supplemental training and will be monitored by with no feedback. After completion of the study all sites will be offered the intervention (as is standard feedback in GIQuIC ).

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: